Gigxone-TZ 500 Injection
Marketer
Primero Life sciences Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Gigxone-TZ 500 Injection
TZ-500 Gigxone injection, a dual-action medication, combats diverse bacterial infections. Its mechanism prevents microbial proliferation and infection spread. Administration must be overseen by a medical professional. Strictly adhere to the prescribed schedule; complete the full course regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects necessitate immediate medical consultation. Seek emergency care for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician about all current medications before commencing treatment. Pregnant or lactating individuals should seek medical advice prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and ample hydration promote faster recovery. Your physician may order laboratory and diagnostic tests to monitor treatment effectiveness.
Uses of Gigxone-TZ 500 Injection
Infections caused by bacteria
Major Benefits of Gigxone-TZ 500 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Gigxone-TZ 500 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Gigxone-TZ 500 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Gigxone-TZ 500 Injection works:
Ceftriaxone and Tazobactum, the components of Gigxone-TZ 500 Injection, act synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial growth. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Gigxone-TZ 500 Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Gigxone-TZ 500 is typically deemed safe for use during gestation. Preclinical trials using animal models revealed minimal or no harmful consequences for the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Gigxone-TZ 500 Injection to breastfeeding mothers requires careful consideration. Nursing should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Gigxone-TZ 500 Injection can induce drowsiness, blurred vision, and dizziness. Driving is strongly discouraged if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Gigxone-TZ 500 Injection's use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Caution is advised when administering Gigxone-TZ 500 Injection to individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is recommended. Altering the Gigxone-TZ 500 Injection dosage is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Gigxone-TZ 500 Injection :
Should you forget a scheduled Gigxone-TZ 500 Injection, seek your physician's advice.
Facts to Know About Gigxone-TZ 500 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently